Tower Research Capital (TRC)’s Indaptus Therapeutics INDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14K | Sell |
108
-17
| -14% | -$179 | ﹤0.01% | 4869 |
|
|
2025
Q1 | $1.92K | Hold |
125
| – | – | ﹤0.01% | 4626 |
|
|
2024
Q4 | $2.96K | Sell |
125
-47
| -27% | -$1.11K | ﹤0.01% | 4741 |
|
|
2024
Q3 | $5.97K | Buy |
172
+25
| +17% | +$867 | ﹤0.01% | 4198 |
|
|
2024
Q2 | $8.7K | Buy |
147
+2
| +1% | +$118 | ﹤0.01% | 4314 |
|
|
2024
Q1 | $9.11K | Sell |
145
-23
| -14% | -$1.45K | ﹤0.01% | 3895 |
|
|
2023
Q4 | $8.27K | Buy |
168
+60
| +56% | +$2.95K | ﹤0.01% | 4526 |
|
|
2023
Q3 | $8.36K | Sell |
108
-94
| -47% | -$7.27K | ﹤0.01% | 4358 |
|
|
2023
Q2 | $10.8K | Sell |
202
-17
| -8% | -$911 | ﹤0.01% | 4034 |
|
|
2023
Q1 | $11K | Sell |
219
-22
| -9% | -$1.11K | ﹤0.01% | 4224 |
|
|
2022
Q4 | $10K | Buy |
241
+229
| +1,908% | +$9.5K | ﹤0.01% | 4015 |
|
|
2022
Q3 | $1K | Sell |
12
-49
| -80% | -$4.08K | ﹤0.01% | 5792 |
|
|
2022
Q2 | $4K | Buy |
+61
| New | +$4K | ﹤0.01% | 5218 |
|
|
2019
Q3 | – | Sell |
-3
| Closed | -$26K | – | 4292 |
|
|
2019
Q2 | $26K | Buy |
+3
| New | +$26K | ﹤0.01% | 2003 |
|
|
2019
Q1 | – | Hold |
0
| – | -$6K | – | 3291 |
|
|
2018
Q4 | – | Hold |
0
| – | -$1K | – | 2798 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 3595 |
|
|
2016
Q2 | – | Hold |
0
| – | -$3K | – | 4680 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 3105 |
|